EFSA Finds Enzyme Safe for Four Food Processes
The European Food Safety Authority updated its safety evaluation of a phospholipase A1 food enzyme produced with a genetically modified Aspergillus oryzae strain.
Updated on Nov. 10, 2026 in Nutrition

The European Food Safety Authority extended its safety evaluation of the food enzyme phospholipase A1, produced by Novozymes A/S using the genetically modified Aspergillus oryzae strain NZYM-LJ, to cover three additional food manufacturing processes. The updated assessment concludes the enzyme raises no safety concerns under the revised conditions of use.
Why it matters
The enzyme is used in food production, so the expanded approval determines which manufacturing processes can rely on it. The conclusion rests on a comparison between estimated consumer exposure and the dose at which no adverse effects were observed in testing.
EFSA calculated maximum European dietary exposure at 1.020 mg TOS/kg body weight per day, against a previously reported no observed adverse effect level of 957.3 mg TOS/kg body weight per day, the highest dose tested. The resulting margin of exposure is at least 939, though the stub does not identify which specific food products fall under the four covered processes.
The players
European Food Safety Authority (EFSA)
EFSA is the European Union agency responsible for scientific advice and risk communication on food safety, including the evaluation of food enzymes.
Novozymes A/S
Novozymes A/S is a Danish biotechnology company that produces industrial enzymes, including the phospholipase A1 food enzyme evaluated here.
The details
EFSA previously evaluated the enzyme for use in one food manufacturing process and, at the applicant's request, extended its evaluation to three more processes, for a total of four. The Panel used the calculated dietary exposure and the earlier dose-response data to conclude the enzyme does not give rise to safety concerns under the revised conditions of use.
Timeline
• Article on the EFSA evaluation published November 10, 2026.
Nutrition Oversight
This extension applies EFSA's established food enzyme evaluation framework, which requires a margin of exposure assessment before a substance is cleared for food use. It follows the agency's pattern of revisiting earlier single-process approvals when applicants request broader use.
Food manufacturers in Europe may use this enzyme in the four covered processes under the revised conditions. The enzyme's presence in foods is governed by the safety margin EFSA reported, not by a finding that the enzyme poses a consumer risk.
The takeaway
Regulators assess food enzymes by comparing estimated exposure against tested doses, and a large margin is the basis for approval. Readers who want to understand what additives they consume can check the applicable regulatory assessments.
Further reading
For broader context on how food ingredients are regulated, see Nutrition.
Source note: This article includes information reported by Foodmate.



